Literature DB >> 1684044

Changes in the levels of inositol lipids and phosphates during the differentiation of HL60 promyelocytic cells towards neutrophils or monocytes.

P J French1, C M Bunce, L R Stephens, J M Lord, F M McConnell, G Brown, J A Creba, R H Michell.   

Abstract

HL60 cells were adapted to grow in a serum-free medium containing 1 mg l-1 inositol, in which they differentiated normally towards neutrophils (in 0.9% by volume dimethylsulphoxide) and towards monocytes (in 10 nM phorbol myristate acetate). Cells that had been equilibrium-labelled with [2-3H]myo-inositol contained a complex pattern of inositol metabolites, several of which were at relatively high concentrations. These included InsP5 and InsP6, which were present at concentrations of about 25 microM and 60 microM, respectively. Striking and different changes occurred in the levels of some of the inositol polyphosphates as the cells differentiated towards either neutrophils or monocytes. Most notable were a large but gradual accumulation of Ins(1,3,4,5,6)P5 as HL60 cells decreased in size and acquired neutrophil characteristics, and much more rapid and sequential declines in InsP4, InsP5 and InsP6 as the cells started to take on monocyte character. There was a marked accumulation of free inositol and of phosphatidylinositol in the cells during neutrophil differentiation, probably caused at least in part by an increased rate of inositol uptake providing an increased intracellular inositol supply. The same accumulation of Ins(1,3,4,5,6)P5 occurred during neutrophil differentiation, whether it was induced by dimethylsulphoxide or by a combination of retinoic acid and a T-lymphocyte cell line-derived differentiation factor. Ins(1,4,5)P3, a physiological intracellular mediator of Ca2+ release from membrane stores, did not change in concentration during these differentiation processes. These observations suggest that some of the more abundant cellular inositol polyphosphates play some important, but not yet understood, role either in the processes of haemopoietic differentiation or in the expression of differentiated cell character in myeloid cells.

Mesh:

Substances:

Year:  1991        PMID: 1684044     DOI: 10.1098/rspb.1991.0109

Source DB:  PubMed          Journal:  Proc Biol Sci        ISSN: 0962-8452            Impact factor:   5.349


  22 in total

1.  Structural and molecular mechanism for autoprocessing of MARTX toxin of Vibrio cholerae at multiple sites.

Authors:  Katerina Prochazkova; Ludmilla A Shuvalova; George Minasov; Zdenek Voburka; Wayne F Anderson; Karla J F Satchell
Journal:  J Biol Chem       Date:  2009-07-20       Impact factor: 5.157

2.  Structure-function analysis of inositol hexakisphosphate-induced autoprocessing of the Vibrio cholerae multifunctional autoprocessing RTX toxin.

Authors:  Katerina Prochazkova; Karla J Fullner Satchell
Journal:  J Biol Chem       Date:  2008-06-30       Impact factor: 5.157

Review 3.  The glycerophosphoinositols: cellular metabolism and biological functions.

Authors:  Daniela Corda; Pasquale Zizza; Alessia Varone; Beatrice Maria Filippi; Stefania Mariggiò
Journal:  Cell Mol Life Sci       Date:  2009-08-09       Impact factor: 9.261

Review 4.  Pharmacogenetics in model systems: defining a common mechanism of action for mood stabilisers.

Authors:  Robin S B Williams
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2005-07       Impact factor: 5.067

5.  A novel context for the 'MutT' module, a guardian of cell integrity, in a diphosphoinositol polyphosphate phosphohydrolase.

Authors:  S T Safrany; J J Caffrey; X Yang; M E Bembenek; M B Moyer; W A Burkhart; S B Shears
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

6.  Inositol 1,3,4,5-tetrakisphosphate negatively regulates phosphatidylinositol-3,4,5- trisphosphate signaling in neutrophils.

Authors:  Yonghui Jia; Kulandayan K Subramanian; Christophe Erneux; Valerie Pouillon; Hidenori Hattori; Hakryul Jo; Jian You; Daocheng Zhu; Stephane Schurmans; Hongbo R Luo
Journal:  Immunity       Date:  2007-09-06       Impact factor: 31.745

7.  Characterization of inositol hexakisphosphate (InsP6)-mediated priming in human neutrophils: lack of extracellular [3H]-InsP6 receptors.

Authors:  E Kitchen; A M Condliffe; A G Rossi; C Haslett; E R Chilvers
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

8.  The inositol phosphates in WRK1 rat mammary tumour cells.

Authors:  N S Wong; C J Barker; A J Morris; A Craxton; C J Kirk; R H Michell
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

9.  Comparison of the levels of inositol metabolites in transformed haemopoietic cells and their normal counterparts.

Authors:  C M Bunce; P J French; P Allen; J C Mountford; B Moor; M F Greaves; R H Michell; G Brown
Journal:  Biochem J       Date:  1993-02-01       Impact factor: 3.857

10.  Complex changes in cellular inositol phosphate complement accompany transit through the cell cycle.

Authors:  Christopher J Barker; Joanne Wright; Philip J Hughes; Christopher J Kirk; Robert H Michell
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.